Literature DB >> 6610353

Systemic lupus erythematosus presenting as chronic serositis with no demonstrable antinuclear antibodies.

J E Ferreiro, W M Reiter, M J Saldana.   

Abstract

Approximately 5 percent of patients with systemic lupus erythematosus by clinical and pathologic criteria have no demonstrable antinuclear antibodies. This figure is likely to be an underestimate, as it does not include the antinuclear antibody-negative patients with limited manifestations in whom the diagnosis of systemic lupus erythematosus is missed. A 23-year-old woman is described who had a history of perplexing bilateral pleural effusions with development of peritoneal effusion after 18 months and positive antinuclear antibody results after 22 months. Tissue pathologic features, initially interpreted as nonspecific, on review revealed striking lymphocytic periarteritis with endothelial swelling and leukocytoclastic vasculitis often seen in systemic lupus. A selective defect in the suppression of T cell effector function, such as direct cell-mediated cytotoxicity, with intact suppressor systems for B cell effector function, such as antibody production, can be postulated in this patient. This would explain the active cellular tissue pathology with the lack of prominent antinuclear antibody production.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6610353     DOI: 10.1016/0002-9343(84)90865-9

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  3 in total

1.  Chronic lupus peritonitis with ascites.

Authors:  P Kaklamanis; G Vayopoulos; G Stamatelos; G Dadinas; G C Tsokos
Journal:  Ann Rheum Dis       Date:  1991-03       Impact factor: 19.103

2.  Hematological Manifestations of SLE at Initial Presentation: Is It Underestimated?

Authors:  P K Sasidharan; M Bindya; K G Sajeeth Kumar
Journal:  ISRN Hematol       Date:  2012-07-09

3.  Kozhikode criteria for diagnosing systemic lupus erythematosus as a hematological disorder.

Authors:  N Arathi; P K Sasidharan; P Geetha
Journal:  J Blood Med       Date:  2016-03-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.